Literature DB >> 1987411

Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes.

H P Chase1, S K Garg, G Marshall, C L Berg, S Harris, W E Jackson, R E Hamman.   

Abstract

The effect of cigarette smoking on diabetic renal and retinal complications was evaluated in 359 young subjects with insulin-dependent diabetes mellitus. The prevalence of increased albumin excretion rates was 2.8 times higher in smokers than nonsmokers. Mean glycohemoglobin levels and duration of diabetes were also significant factors in the development of diabetic nephropathy and retinopathy in a logistic regression model. Smoking remained a significant factor in the logistic regression model for albuminuria (but not retinopathy) when controlled for glycohemoglobin level, duration of diabetes, age, gender, and blood pressure. The progression of albuminuria and of retinopathy was also greater in smokers. Albuminuria improved significantly when subjects ceased smoking. It is concluded that cigarette smoking is an independent risk factor and is associated with the development and progression of early diabetic renal damage (albuminuria) and with the worsening of retinal disease in young subjects with diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987411

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  43 in total

Review 1.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

2.  Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study.

Authors:  Amy S Shah; Dana Dabelea; Jennifer W Talton; Elaine M Urbina; Ralph B D Agostino; R Paul Wadwa; Santica Marcovina; Richard F Hamman; Stephen R Daniels; Lawrence M Dolan
Journal:  J Pediatr       Date:  2014-03-27       Impact factor: 4.406

3.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

Review 4.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

5.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

6.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 7.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

8.  Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.

Authors:  C A Jones; G P Leese; S Kerr; K Bestwick; D I Isherwood; J P Vora; D A Hughes; C Smith
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

9.  Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom.

Authors: 
Journal:  BMJ       Date:  1993-05-08

10.  Leucocyte count, proteinuria and smoking in type 1 diabetes mellitus.

Authors:  I Mühlhauser; R Verhasselt; P T Sawicki; M Berger
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.